Heart pump therapy shows promise for long COVID sufferers
NCT ID NCT07492953
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a non-invasive treatment called enhanced external counterpulsation (EECP) can improve heart and lung function in adults with long COVID. Ten participants received EECP therapy on one of two schedules. Researchers measured exercise capacity, symptoms, and safety to see if the therapy helps recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Natioanl Denfense Medical University
Taipei, 114, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can our genes and gut explain long COVID?
- Brain fog after COVID: can a mental workout restore focus?
- Fish oil and Body's own healing molecules could lift long COVID depression
- Zapping the brain to clear long COVID fog: a new hope?
- Can tailored exercise help tame racing heart and fatigue after COVID?
- Mind over fatigue: could a 3-Day program tame long COVID?